Milestone Pharmaceuticals IncNASDAQ:MIST
- LAST PRICE1.4600
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots1.4000/ 2
- Ask / Lots1.4600/ 10
- Open / Previous Close1.4600 / 1.4600
- Day Range
- 52 Week Range
- Volume147,612
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MIST |
|---|---|---|
| 09:32 ET | 1950 | 1.46 |
| 09:36 ET | 200 | 1.469 |
| 10:06 ET | 1458 | 1.465 |
| 10:17 ET | 165 | 1.45 |
| 10:30 ET | 100 | 1.45 |
| 10:32 ET | 695 | 1.4592 |
| 10:33 ET | 790 | 1.4525 |
| 10:46 ET | 1300 | 1.45 |
| 10:55 ET | 3287 | 1.46 |
| 10:57 ET | 225 | 1.4534 |
| 11:02 ET | 1546 | 1.45 |
| 11:04 ET | 16777 | 1.425 |
| 11:06 ET | 1100 | 1.425 |
| 11:08 ET | 1800 | 1.43 |
| 11:15 ET | 600 | 1.44 |
| 11:18 ET | 6104 | 1.43 |
| 11:24 ET | 100 | 1.45 |
| 11:26 ET | 5000 | 1.4317 |
| 11:31 ET | 600 | 1.45 |
| 11:33 ET | 350 | 1.44 |
| 11:36 ET | 500 | 1.449 |
| 11:40 ET | 100 | 1.45 |
| 11:49 ET | 100 | 1.44 |
| 11:58 ET | 100 | 1.44 |
| 12:07 ET | 100 | 1.44 |
| 12:21 ET | 1000 | 1.445 |
| 12:25 ET | 100 | 1.45 |
| 12:43 ET | 100 | 1.45 |
| 12:45 ET | 1190 | 1.4488 |
| 12:54 ET | 1200 | 1.45 |
| 12:56 ET | 100 | 1.44 |
| 01:03 ET | 100 | 1.45 |
| 01:12 ET | 400 | 1.44 |
| 01:21 ET | 100 | 1.45 |
| 01:33 ET | 100 | 1.45 |
| 01:35 ET | 5666 | 1.44 |
| 01:44 ET | 800 | 1.43 |
| 01:51 ET | 293 | 1.4206 |
| 01:53 ET | 300 | 1.42 |
| 01:57 ET | 1500 | 1.41 |
| 02:00 ET | 5737 | 1.4 |
| 02:02 ET | 2260 | 1.42 |
| 02:06 ET | 624 | 1.4191 |
| 02:08 ET | 3141 | 1.4107 |
| 02:09 ET | 500 | 1.415 |
| 02:11 ET | 28696 | 1.41 |
| 02:13 ET | 1500 | 1.41 |
| 02:15 ET | 714 | 1.405 |
| 02:24 ET | 2000 | 1.4099 |
| 02:26 ET | 4425 | 1.41 |
| 02:27 ET | 1400 | 1.405 |
| 02:29 ET | 100 | 1.41 |
| 02:38 ET | 1294 | 1.41 |
| 02:42 ET | 200 | 1.41 |
| 02:47 ET | 100 | 1.42 |
| 02:51 ET | 8163 | 1.4199 |
| 02:56 ET | 500 | 1.42 |
| 03:02 ET | 300 | 1.4197 |
| 03:03 ET | 100 | 1.42 |
| 03:05 ET | 2100 | 1.4194 |
| 03:07 ET | 17072 | 1.42 |
| 03:09 ET | 1237 | 1.43 |
| 03:12 ET | 100 | 1.44 |
| 03:18 ET | 100 | 1.44 |
| 03:25 ET | 700 | 1.4215 |
| 03:32 ET | 100 | 1.44 |
| 03:38 ET | 100 | 1.44 |
| 03:41 ET | 100 | 1.44 |
| 03:48 ET | 100 | 1.44 |
| 03:50 ET | 200 | 1.44 |
| 03:54 ET | 100 | 1.44 |
| 03:57 ET | 500 | 1.45 |
| 03:59 ET | 662 | 1.46 |
May 31, 2024
Milestone(R) Pharmaceuticals to Participate in the Upcoming Jefferies Global Healthcare Conference, from 8:00AM ET on Friday May 31, 2024 by Dow Jones
8:00AM ET on Friday May 31, 2024 by Dow Jones
May 30, 2024
DJ Milestone Pharmaceuticals Price Target Maintained With a $25.00/Share by HC Wainwright & Co., from 7:23AM ET on Thursday May 30, 2024 by Dow Jones
7:23AM ET on Thursday May 30, 2024 by Dow Jones
May 29, 2024
Milestone Pharmaceuticals Announces FDA Acceptance of New Drug Application for CARDAMYST(TM), from 7:00AM ET on Wednesday May 29, 2024 by Dow Jones
7:00AM ET on Wednesday May 29, 2024 by Dow Jones
May 22, 2024
Milestone Pharmaceuticals Partners with Arrhythmia Alliance on SVT Awareness, from 8:00AM ET on Wednesday May 22, 2024 by Dow Jones
8:00AM ET on Wednesday May 22, 2024 by Dow Jones
May 16, 2024
DJ Milestone Pharmaceuticals Price Target Maintained With a $25.00/Share by HC Wainwright & Co., from 8:02AM ET on Thursday May 16, 2024 by Dow Jones
8:02AM ET on Thursday May 16, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Milestone Pharmaceuticals Inc | 78.8M | -1.2x | --- |
Provectus Biopharmaceuticals Inc | 77.5M | -25.7x | --- |
Barinthus Biotherapeutics PLC | 74.0M | -1.0x | --- |
Bioatla Inc | 79.4M | -0.6x | --- |
Anixa Biosciences Inc | 75.3M | -7.7x | --- |
Serina Therapeutics Inc | 82.0M | -0.7x | --- |
Company Information
Milestone Pharmaceuticals Inc. is a Canada-based biopharmaceutical company. The Company is focused on the development and commercialization of cardiovascular medicines. Its lead product candidate, etripamil, is a potent rapid-onset calcium channel blocker that the Company designed and is developing as a rapid-onset nasal spray to be administered by patients. The Company is also focused on developing etripamil to treat paroxysmal supraventricular tachycardia (PSVT) with a subsequent indication to treat atrial fibrillation with rapid ventricular rate (AFib-RVR) and other cardiovascular indications.
Contact Information
- Headquarters
- 420-1111 boul. Dr.-Frederik-PhilipsMONTREAL, QC, Canada H4M 2X6
- Phone
- 514-336-0444
- Fax
- 514-336-0444
Executives
- Non-Executive Independent Chairman of the Board
- Robert Wills
- President, Chief Executive Officer
- Joseph Oliveto
- Chief Financial Officer, Executive Vice President of Corporate Development
- Amit Hasija
- Chief Operating Officer
- Jeffrey Nelson
- Chief Medical Officer
- David Bharucha
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $78.8M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 53.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.66 |
EPS | $-1.25 |
Book Value | $0.50 |
P/E Ratio | -1.2x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
